{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T06:55:45Z","timestamp":1784098545808,"version":"3.55.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T00:00:00Z","timestamp":1750032000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["310030 185292"],"award-info":[{"award-number":["310030 185292"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["310030 185292"],"award-info":[{"award-number":["310030 185292"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["310030 185292"],"award-info":[{"award-number":["310030 185292"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["310030 185292"],"award-info":[{"award-number":["310030 185292"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["847941"],"award-info":[{"award-number":["847941"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["847941"],"award-info":[{"award-number":["847941"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["847941"],"award-info":[{"award-number":["847941"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012653","name":"Fondation Novartis Consumer Health","doi-asserted-by":"publisher","award":["18A052"],"award-info":[{"award-number":["18A052"]}],"id":[{"id":"10.13039\/501100012653","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BJC Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>The pituitary gland is a main component of the endocrine system and a master controller of hormone production and secretion. Unlike neoplastic formation in other organs, Pituitary Neuroendocrine Tumors (PitNETs) are frequent in the population (16%) and, for unknown reasons, almost never metastatic. So far, few genes have been identified as drivers for PitNETs, such as <jats:italic>GNAS<\/jats:italic> in somatotroph tumors and <jats:italic>USP8<\/jats:italic> in corticotroph tumors. Using whole genome sequencing, we uncover a potential novel driver, the histone methyltransferase <jats:italic>KMT2D<\/jats:italic>, in a patient in his 50s suffering from a mixed somato-lactotroph tumor. Coverage ratio between germline and tumor revealed extensive chromosomal alterations. Single-cell RNA sequencing of the tumor shows up-regulation of known tumorigenic pathways compared to a healthy reference, as well as a different immune infiltration profile compared to other PitNETs, more closely resembling the profile of carcinomas than adenomas. Genome-wide DNA methylation analysis identified 796 differentially methylated regions, including notable hypomethylation in the promoter of <jats:italic>SPON2<\/jats:italic>, an immune-related gene. Our results show that tumors considered quiet and non-aggressive can share drivers, features, and epigenetic alterations with metastatic forms of cancer, raising questions about the biological mechanisms controlling their homeostasis.<\/jats:p>","DOI":"10.1038\/s44276-025-00155-0","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T11:32:23Z","timestamp":1750073543000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Whole genome sequencing and single-cell transcriptomics identify KMT2D inactivation as a potential new driver for pituitary tumors: a case report"],"prefix":"10.1038","volume":"3","author":[{"given":"Maxime","family":"Brunner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Meylan-Merlini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maude","family":"Muriset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey","family":"Oreshkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Messina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Messerer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekkehard","family":"Hewer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Phillipe","family":"Brouland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Santoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,16]]},"reference":[{"key":"155_CR1","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/cncr.20412","volume":"101","author":"S Ezzat","year":"2004","unstructured":"Ezzat S, Asa SL, Couldwell WT, Barr CE, Dodge WE, Vance ML, et al. The prevalence of pituitary adenomas: A systematic review. Cancer. 2004;101:613\u20139.","journal-title":"Cancer"},{"key":"155_CR2","doi-asserted-by":"crossref","unstructured":"Ostrom QT, Cioffi G, Gittleman H, Patil N, Waite K, Kruchko C, et al. CBTRUS statistical report: Primary brain and other central nervous system tumors diagnosed in the United States in 2012\u20132016. Neuro-Oncology. 2019;21:v1\u2013v100.","DOI":"10.1093\/neuonc\/noz150"},{"key":"155_CR3","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1530\/eje.1.02326","volume":"156","author":"DK Ludecke","year":"2007","unstructured":"Ludecke DK, Buchfelder M, Fahlbusch R, Quabbe HJ, Petersenn S, Saeger W. Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry. Eur J Endocrinol. 2007;156:203\u201316.","journal-title":"Eur J Endocrinol"},{"key":"155_CR4","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1001\/jama.2016.19699","volume":"317","author":"ME Molitch","year":"2017","unstructured":"Molitch ME. Diagnosis and treatment of pituitary adenomas: A review. JAMA - J Am Med Assoc. 2017;317:516\u201324.","journal-title":"JAMA - J Am Med Assoc"},{"key":"155_CR5","doi-asserted-by":"publisher","first-page":"314","DOI":"10.3803\/EnM.2019.34.3.314","volume":"34","author":"YH Kim","year":"2019","unstructured":"Kim YH, Kim JH. Transcriptome analysis identifies an attenuated local immune response in invasive nonfunctioning pituitary adenomas. Endocrinol Metab. 2019;34:314\u201322.","journal-title":"Endocrinol Metab"},{"key":"155_CR6","doi-asserted-by":"crossref","unstructured":"Cossu G, Rosa SL, Brouland JP, Pitteloud N, Harel E, Santoni F, et al. PD-L1 expression in pituitary neuroendocrine tumors\/pituitary adenomas. Cancers 2023;15:20726694.","DOI":"10.3390\/cancers15184471"},{"key":"155_CR7","doi-asserted-by":"crossref","unstructured":"Asa SL, Mete O, Perry A, Osamura RY. Overview of the 2022 WHO Classification of Pituitary Tumors. Endocr Pathol. 2022;33:6\u201326.","DOI":"10.1007\/s12022-022-09703-7"},{"key":"155_CR8","doi-asserted-by":"crossref","unstructured":"Beckers A, Aaltonen LA, Daly AF, Karhu A. Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene. Endocr Rev. 2013;34:239\u201377.","DOI":"10.1210\/er.2012-1013"},{"key":"155_CR9","doi-asserted-by":"crossref","unstructured":"Kamilaris CDC, Stratakis CA. Multiple Endocrine Neoplasia Type 1 (MEN1): An Update and the Significance of Early Genetic and Clinical Diagnosis. Front Endocrinol (Lausanne). 2019;10:339.","DOI":"10.3389\/fendo.2019.00339"},{"key":"155_CR10","doi-asserted-by":"crossref","unstructured":"Peculis R, Rovite V, Megnis K, Balcere I, Breiksa A, Nazarovs J, et al. Whole exome sequencing reveals novel risk genes of pituitary neuroendocrine tumors. PLoS ONE 2022;17:19326203.","DOI":"10.1371\/journal.pone.0265306"},{"key":"155_CR11","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/cr.2015.20","volume":"25","author":"ZY Ma","year":"2015","unstructured":"Ma ZY, Song ZJ, Chen JH, Wang YF, Li SQ, Zhou LF, et al. Recurrent gain-of-function USP8 mutations in Cushing\u2019s disease. Cell Res. 2015;25:306\u201317.","journal-title":"Cell Res"},{"key":"155_CR12","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1530\/EJE-15-1064","volume":"174","author":"CL Ronchi","year":"2016","unstructured":"Ronchi CL, Peverelli E, Herterich S, Weigand I, Mantovani G, Schwarzmayr T, et al. Landscape of somatic mutations in sporadic GH-secreting pituitary adenomas. Eur J Endocrinol. 2016;174:363\u201372.","journal-title":"Eur J Endocrinol"},{"key":"155_CR13","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1007\/s12519-019-00309-4","volume":"15","author":"YR Wang","year":"2019","unstructured":"Wang YR, Xu NX, Wang J, Wang XM. Kabuki syndrome: review of the clinical features, diagnosis and epigenetic mechanisms. World J Pediatrics. 2019;15:528\u201335.","journal-title":"World J Pediatrics"},{"key":"155_CR14","doi-asserted-by":"crossref","unstructured":"Tinsley E, Bredin P, Toomey S, Hennessy BT, Furney SJ. KMT2C and KMT2D aberrations in breast cancer. Trends Cancer. 2024;10:519\u201330.","DOI":"10.1016\/j.trecan.2024.02.003"},{"key":"155_CR15","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ccell.2022.11.015","volume":"41","author":"Y Pan","year":"2023","unstructured":"Pan Y, Han H, Hu H, Wang H, Song Y, Hao Y, et al. KMT2D deficiency drives lung squamous cell carcinoma and hypersensitivity to RTK-RAS inhibition. Cancer Cell. 2023;41:88\u2013105.e8.","journal-title":"Cancer Cell"},{"key":"155_CR16","doi-asserted-by":"crossref","unstructured":"Li J, Chin CR, Ying HY, Meydan C, Teater MR, Xia M, et al. Loss of CREBBP and KMT2D cooperate to accelerate lymphomagenesis and shape the lymphoma immune microenvironment. Nat Commun. 2024;15:2879.","DOI":"10.1038\/s41467-024-47012-1"},{"key":"155_CR17","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.cell.2018.12.015","volume":"176","author":"K Jaganathan","year":"2019","unstructured":"Jaganathan K, Panagiotopoulou SK, McRae JF, Darbandi SF, Knowles D, Li YI, et al. Predicting splicing from primary sequence with deep learning. Cell. 2019;176:535\u2013548.e24.","journal-title":"Cell"},{"key":"155_CR18","doi-asserted-by":"publisher","first-page":"13534","DOI":"10.1093\/nar\/gku1206","volume":"42","author":"X Jian","year":"2014","unstructured":"Jian X, Boerwinkle E, Liu X. In silico prediction of splice-altering single nucleotide variants in the human genome. Nucleic Acids Res. 2014;42:13534\u201344.","journal-title":"Nucleic Acids Res"},{"key":"155_CR19","doi-asserted-by":"crossref","unstructured":"Zhang, Q, Yao, B, Long, X, Chen, Z, He, M, Wu, Y, et al. Single-cell sequencing identifies differentiation-related markers for molecular classification and recurrence prediction of PitNET. Cell Rep Med. 2023;4:26663791.","DOI":"10.1016\/j.xcrm.2023.100934"},{"key":"155_CR20","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao Y, Hao S, Andersen-Nissen E, Mauck WM, Zheng S, Butler A, et al. Integrated analysis of multimodal single-cell data. Cell. 2021;184:3573\u201387.e29.","journal-title":"Cell"},{"key":"155_CR21","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s12022-015-9383-6","volume":"26","author":"JQ Lu","year":"2015","unstructured":"Lu JQ, Adam B, Jack AS, Lam A, Broad RW, Chik CL. Immune cell infiltrates in pituitary adenomas: more macrophages in larger adenomas and more T cells in growth hormone adenomas. Endocr Pathol. 2015;26:263\u201372.","journal-title":"Endocr Pathol"},{"key":"155_CR22","doi-asserted-by":"crossref","unstructured":"Zhang Q, Wang XQ, Wang J, Cui SJ, Lou XM, Yan B, et al. Upregulation of spondin-2 predicts poor survival of colorectal carcinoma patients. Oncotarget. 2015;6:15095.","DOI":"10.18632\/oncotarget.3822"},{"key":"155_CR23","doi-asserted-by":"crossref","unstructured":"Kim JW, Kim ST, Turner AR, Young T, Smith S, Liu W, et al. Identification of new differentially methylated genes that have potential functional consequences in prostate cancer. PLoS ONE 2012;7:19326203.","DOI":"10.1371\/journal.pone.0048455"},{"key":"155_CR24","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.ccell.2019.11.002","volume":"37","author":"M Neou","year":"2020","unstructured":"Neou M, Villa C, Armignacco R, Jouinot A, Raffin-Sanson ML, Septier A, et al. Pangenomic Classification of Pituitary Neuroendocrine Tumors. Cancer Cell. 2020;37:123\u2013134.e5.","journal-title":"Cancer Cell"},{"key":"155_CR25","doi-asserted-by":"crossref","unstructured":"Dhar SS, Lee MG. Cancer-epigenetic function of the histone methyltransferase KMT2D and therapeutic opportunities for the treatment of KMT2D-deficient tumors. Oncotarget. 2021;12:1296\u2013308.","DOI":"10.18632\/oncotarget.27988"},{"key":"155_CR26","doi-asserted-by":"crossref","unstructured":"Wang DX, Long JY, Li RZ, Zhang DL, Liu H, Liu J, et al. Mutation status of the KMT2 family associated with immune checkpoint inhibitors (ICIs) therapy and implicating diverse tumor microenvironments. Mol Cancer. 2024;23:15.","DOI":"10.1186\/s12943-023-01930-8"},{"key":"155_CR27","doi-asserted-by":"publisher","first-page":"2206098","DOI":"10.1002\/advs.202206098","volume":"10","author":"J Xu","year":"2023","unstructured":"Xu J, Zhong A, Zhang S, Chen M, Zhang L, Hang X, et al. KMT2D deficiency promotes myeloid leukemias which is vulnerable to ribosome biogenesis inhibition. Adv Sci. 2023;10:2206098.","journal-title":"Adv Sci"},{"key":"155_CR28","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1038\/s41388-017-0026-x","volume":"37","author":"S Lv","year":"2018","unstructured":"Lv S, Ji L, Chen B, Liu S, Lei C, Liu X, et al. Histone methyltransferase KMT2D sustains prostate carcinogenesis and metastasis via epigenetically activating LIFR and KLF4. Oncogene. 2018;37:1354\u201368.","journal-title":"Oncogene"},{"key":"155_CR29","doi-asserted-by":"crossref","unstructured":"Hillman, RT, Celestino, J, Terranova, C, Beird, HC, Gumbs, C, Little, L, et al. KMT2D\/MLL2 inactivation is associated with recurrence in adult-type granulosa cell tumors of the ovary. Nat. Commun. 2018;9:20411723.","DOI":"10.1038\/s41467-018-04950-x"},{"key":"155_CR30","first-page":"1309","volume":"12","author":"C Dauch","year":"2022","unstructured":"Dauch C, Shim S, Cole MW, Pollock NC, Beer AJ, Ramroop J, et al. KMT2D loss drives aggressive tumor phenotypes in cutaneous squamous cell carcinoma. en. Am J Cancer Res. 2022;12:1309\u201322.","journal-title":"Am J Cancer Res"},{"key":"155_CR31","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.ccell.2020.03.005","volume":"37","author":"H Alam","year":"2020","unstructured":"Alam H, Tang M, Maitituoheti M, Dhar SS, Kumar M, Han CY, et al. KMT2D deficiency impairs super-enhancers to confer a glycolytic vulnerability in lung cancer. Cancer Cell. 2020;37:599\u2013617.e7.","journal-title":"Cancer Cell"},{"key":"155_CR32","doi-asserted-by":"publisher","unstructured":"Freed D, Aldana R, Weber JA, Edwards JS. The Sentieon Genomics Tools - A fast and accurate solution to variant calling from next-generation sequence data. bioRxiv 115717 https:\/\/doi.org\/10.1101\/115717.","DOI":"10.1101\/115717"},{"key":"155_CR33","doi-asserted-by":"publisher","unstructured":"Freed D, Pan R, Aldana R. TNscope: Accurate Detection of Somatic Mutations with Haplotype-based Variant Candidate Detection and Machine Learning Filtering. bioRxiv 250647 https:\/\/doi.org\/10.1101\/250647.","DOI":"10.1101\/250647"},{"key":"155_CR34","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/s41586-023-06045-0","volume":"625","author":"S Chen","year":"2024","unstructured":"Chen S, Francioli LC, Goodrich JK, Collins RL, Kanai M, Wang Q, et al. A genomic mutational constraint map using variation in 76,156 human genomes. Nature. 2024;625:92\u2013100.","journal-title":"Nature"},{"key":"155_CR35","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/s41587-023-01767-y","volume":"42","author":"Y Hao","year":"2024","unstructured":"Hao Y, Stuart T, Kowalski MH, Choudhary S, Hoffman P, Hartman A, et al. Dictionary learning for integrative, multimodal and scalable single-cell analysis. Nat Biotechnol. 2024;42:293\u2013304.","journal-title":"Nat Biotechnol"},{"key":"155_CR36","doi-asserted-by":"crossref","unstructured":"Squair JW, Gautier M, Kathe C, Anderson MA, James ND, Hutson TH, et al. Confronting false discoveries in single-cell differential expression. Nat Commun. 2021;12:5692.","DOI":"10.1038\/s41467-021-25960-2"},{"key":"155_CR37","doi-asserted-by":"publisher","unstructured":"Korotkevich G, Sukhov V, Budin N, Shpak B, Artyomov MN, Sergushichev A. Fast gene set enrichment analysis. bioRxiv 060012; https:\/\/doi.org\/10.1101\/060012.","DOI":"10.1101\/060012"}],"container-title":["BJC Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s44276-025-00155-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44276-025-00155-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s44276-025-00155-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T11:32:31Z","timestamp":1750073551000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s44276-025-00155-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,16]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["155"],"URL":"https:\/\/doi.org\/10.1038\/s44276-025-00155-0","relation":{},"ISSN":["2731-9377"],"issn-type":[{"value":"2731-9377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,16]]},"assertion":[{"value":"26 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study has been performed in accordance with the Declaration of Helsinki and approved by the Commission cantonale d\u2019\u00b4ethique de la recherche sur l\u2019\u02c6etre humain (Vaud) ref. 2019-02033. All patients have signed the informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"43"}}